Navigate Fool.com
Will BCRX beat
the market?
Community Rating: 1 Star: Ominous

8.55 0.00 (0.00%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $9.23
Previous Close $8.55
Daily Range $8.40 - $9.23
52-Week Range $1.42 - $13.33
Market Cap $507.7M
P/E Ratio -16.73
Dividend (Yield) $0.00 (0.0%)
Volume 641,237
Average Daily Volume 871,218
Current FY EPS -$0.74

How do you think BCRX
will perform against the market?

Top BCRX Bull/Bear Pitches


TMFBiologyFool (< 20)
Submitted March 9, 2011

Will rise during next pandemic flu. When will that happen? I have no idea, but at this cheap price, it's not that hard to wait.

0 Replies Reply Report this Post

acecannon (< 20)
Submitted April 18, 2007

It's not a matter of if, but when, the stock goes to 0. My pick is for an outbreak of 0 in Asia first, followed by Canada, then lastly America.

0 Replies Reply Report this Post

News & Commentary Rss Feed

BioCryst Pharmaceuticals Q4 Loss Shrinks 51% on Higher Collaborative Revenue

BioCryst Pharmaceuticals reports a big jump in revenue amid tame expense growth, but investors will want to note the company's current cash balance and expected burn rate for 2014.

Sector Update: Healthcare Shares Flat to Higher Pre-Market; BioCryst Q4 Results Mixed

Sector Update: Healthcare

Why BioCryst Pharmaceuticals, Inc. Shares Spiked Higher

BioCryst Pharmaceuticals shares soar after favorable news from the Food and Drug Administration. Here's why investors may want to remain cautious over the near term.

Today's Biggest Biotech Stories: BioCryst, Verastem, and InterMune

BioCryst, Verastem, and InterMune could all loom large in health care headlines this morning. Here's why.

Today's Biggest Biotech Stories: Antares Pharma Inc., BioCryst Pharmaceuticals Inc., and Raptor Phar

Today's movers in biotech.

Top Analyst Upgrades and Downgrades: Apple, BioCryst, Dow Chemical, Sanmina, Sally Beauty and More

Top Analyst Upgrades and Downgrades: Cisco, Lululemon, Nokia, Peabody, Xerox and More

Sector Update: Healthcare Shares Mixed

Sector Update: Healthcare

See More BCRX News...





BioCryst Pharmaceuticals, Inc. (BCRX) Description

A biotechnology company, which designs, optimizes and develops novel drugs that block key enzymes involved in cancer, cardiovascular diseases, autoimmune diseases, and viral infections. Website: http://www.biocryst.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks